Wulff Capital assists African entrepreneurs in commercializing their health innovations. These innovative products can improve wellbeing and lower health costs on a global scale. Product commercialization can create new jobs and protect botanic diversity.

Due Diligence
Their extensive network of business incubation professionals recruit the best innovations and entrepreneurs to participate in Wulff's program. They screen these entrepreneurs for passion, expertise, and ethics. Then they screen their products for market demand, competitive environment and profit potential.

Entrepreneur Support
Once they have chosen to work with an entrepreneur, they support his/her product commercialization with:

* Advice on strategy, product and business development;

* Industry representation;

* Capital resource introductions;

* Agreement negotiations; and

* Sales and Marketing assistance.

Sector Focus
Their current focus is on Africeuticals™, innovative products based on African botanicals. Africeutical products address critical health needs in innovative ways. Their commercialization methods help build sustainable indigenous industries.

Industry Partnering
U.S. corporations seek novel products and new markets. Wulff's Africeutical entrepreneurs offer both.

Investment Partnering
Wulff's products offer multiple bottom lines:

* Competitive returns on investments
* Social returns by creating new employment
* Health returns by providing improved health products
* Environmental returns by preserving biodiversity